scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

Q: What does CUSIP 810648105 represent in this 13F holders report?

CUSIP 810648105 is the security identifier for SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in Q1 2022?

34 institutional investors reported SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 810648105

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 15,882,655
Total 13F value: $90,121,602
Share change: -75,465
SEC-reported price per share: $5.68
Number of holders: 34
Value change: -$464,823
Number of buys: 11
Number of sells: 12
Shares outstanding: 53,364,241

Security key

810648105

Report period

Q1 2022

Institutions

Top holders

SCPH full security history Ownership snapshot Full 13F holder table scPharmaceuticals Inc. SEC filings scPharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 9% Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 9%

5AM Venture Management, LLC 7.2%

RA CAPITAL MANAGEMENT, L.P. 5%

AIGH Capital Management LLC 2.6%

Ikarian Capital, LLC 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	9%	$24,082,000 4,797,148 shares	—	31 Dec 2021
5AM Venture Management, LLC	13F Company 13F	7.2%	$19,234,000 3,831,474 shares	—	31 Dec 2021
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	5%	$13,513,000 2,691,770 shares	—	31 Dec 2021
AIGH Capital Management LLC	13F Company 13F	2.6%	$6,893,000 1,373,124 shares	—	31 Dec 2021
Ikarian Capital, LLC	13F Company 13F	1.7%	$4,525,000 901,362 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	1.2%	$3,095,000 616,558 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,882,655

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %